No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic Doses

Documenti analoghi

• Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
  di: Eugenio Mercuri, et al.
  Pubblicazione: (2026)
• Lack of Concentration‐QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses
  di: Lucy Lee, et al.
  Pubblicazione: (2024)
• Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study
  di: Borje Darpo, et al.
  Pubblicazione: (2024)
• Concentration‐QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study
  di: Wei Yin, et al.
  Pubblicazione: (2024)
• The Impact of QT‐Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case‐Crossover Study
  di: Hsiu‐Ting Chien, et al.
  Pubblicazione: (2024)